
© 2025 4investors
Realtime | Geld | Brief | Zeit |
---|---|---|---|
1,566 | 1,594 | 21:24 | |
1,566 | 1,593 | 21:21 |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Di | Raymond James maintains Strong Buy on Inflarx stock, $13 target | ||
07.05. | InflaRx N.V. - 6-K, Report of foreign issuer | ||
07.05. | InflaRx GAAP EPS of -€0.13 | ||
07.05. | InflaRx N.V.: InflaRx Reports First Quarter 2025 Financial Results and Provides Business Update | Announces successful completion of sub-chronic and chronic toxicology studies for INF904, supporting long-term dosing in future clinical trialsMultiple near-term catalysts anticipated with the potential... ► Artikel lesen | |
06.05. | Preview: InflaRx's Earnings |